When ATH:
N06BX04
Pharmacological action.
Nootropic, tserebroprotektyvnoe, antiastenicheskoe, antidepressant, gepatoprotektivnoe.
Application.
Asthenic and asthenic-depressive disorder (border states, psycho-organic syndrome, schizophrenia, alcoholism), neuroleptic syndrome (mild to moderate symptoms), alcohol withdrawal syndrome with predominance of asthenic disorders and somatovegetativnyh, intellectual-mental disorders, neurotic and neurosis-like disorders in the background of residual-organic inferiority CNS, psychosomatic disorders.
Acute and chronic hepatitis, cirrhosis of the liver, cholestasis, fatty liver disease of various origins, incl. Alcoholic; the combination of depressive disorders and diseases of the liver.
Contraindications.
Hypersensitivity.
Side effects.
Allergic reactions.
Dosing and Administration.
Inside, by 1 c.lojke (5 ml contains 1 Mr. deanol atseglumata) 23 times a day during daylight hours (last admission - not later 18 no). The maximum single dose - 2 g, The maximum daily dose - 10 g. The course of treatment - 1.5-2 months.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More